M&A Deal Summary

FluoroPharma Acquires Ground Fluor Pharmaceuticals

On June 9, 2016, FluoroPharma acquired life science company Ground Fluor Pharmaceuticals

Acquisition Highlights
  • This is FluoroPharma’s 1st transaction in the Life Science sector.
  • This is FluoroPharma’s 1st transaction in the United States.
  • This is FluoroPharma’s 1st transaction in Nebraska.

M&A Deal Summary

Date 2016-06-09
Target Ground Fluor Pharmaceuticals
Sector Life Science
Buyer(s) FluoroPharma
Deal Type Add-on Acquisition

Target

Ground Fluor Pharmaceuticals

Lincoln, Nebraska, United States
website
Ground Fluor Pharmaceuticals, Inc. (GFP) is a company based in Lincoln, NE and Cambridge, MA that has developed new chemistry technology which transforms complicated and costly fluorine syntheses into simpler, more efficient processes. Using technology developed at the University of Nebraska and the Massachusetts General Hospital and funded by the National Science Foundation and Cedarville Investments, Ltd., GFP has developed and patented processes and intermediate chemicals for the efficient, cost-effective production of PET imaging agents.

Search 193,103 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

FluoroPharma

Montclair, New Jersey, United States

website


Category Company
Founded 2003
Sector Life Science
Employees4
DESCRIPTION

FluoroPharma is a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. The Company has licensed technology from the Massachusetts General Hospital in Boston. The Company's goal is to enable personalized medicine through precision diagnostics that will help the medical community diagnose disease more accurately at the earliest stages, leading to more effective treatment, management and better patient outcomes. FluoroPharma was incorporated in 2003 and is based in Montclair, New Jersey.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Nebraska) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1